TTNP logo

Titan Pharmaceuticals (TTNP) Working Capital

Annual Working Capital

$6.57 M
+$5.60 M+575.64%

31 December 2023

TTNP Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$3.99 M
-$2.06 M-34.01%

30 June 2024

TTNP Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTNP Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--39.3%
3 y3 years+44.2%-12.4%
5 y5 years+39.6%-15.2%

TTNP Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+575.6%-50.3%+396.3%
5 y5 years-33.3%+575.6%-57.7%+396.3%
alltimeall time-94.3%+202.7%-96.5%+162.4%

Titan Pharmaceuticals Working Capital History

DateAnnualQuarterly
June 2024
-
$3.99 M(-34.0%)
Mar 2024
-
$6.05 M(-7.9%)
Dec 2023
$6.57 M(+575.6%)
$6.57 M(-18.2%)
Sept 2023
-
$8.03 M(-695.9%)
June 2023
-
-$1.35 M(+103.6%)
Mar 2023
-
-$662.00 K(-168.0%)
Dec 2022
$973.00 K(-78.7%)
$973.00 K(-68.8%)
Sept 2022
-
$3.12 M(-39.9%)
June 2022
-
$5.19 M(-29.4%)
Mar 2022
-
$7.36 M(+61.3%)
Dec 2021
$4.56 M(+46.9%)
$4.56 M(-34.1%)
Sept 2021
-
$6.92 M(-14.7%)
June 2021
-
$8.11 M(-14.0%)
Mar 2021
-
$9.43 M(+203.8%)
Dec 2020
$3.10 M(-34.0%)
$3.10 M(+302.2%)
Sept 2020
-
$772.00 K(-79.9%)
June 2020
-
$3.83 M(-50.5%)
Mar 2020
-
$7.74 M(+64.3%)
Dec 2019
$4.71 M(-52.2%)
$4.71 M(+914.7%)
Sept 2019
-
$464.00 K(-59.7%)
June 2019
-
$1.15 M(-78.4%)
Mar 2019
-
$5.33 M(-45.9%)
Dec 2018
$9.85 M(+156.1%)
$9.85 M(+5.6%)
Sept 2018
-
$9.32 M(+416.8%)
June 2018
-
$1.80 M(-11.2%)
Mar 2018
-
$2.03 M(-47.2%)
Dec 2017
$3.85 M(-70.4%)
$3.85 M(-61.9%)
Sept 2017
-
$10.08 M(+46.5%)
June 2017
-
$6.88 M(-31.4%)
Mar 2017
-
$10.04 M(-22.6%)
Dec 2016
$12.97 M(+75.5%)
$12.97 M(-18.7%)
Sept 2016
-
$15.96 M(-12.9%)
June 2016
-
$18.32 M(+210.1%)
Mar 2016
-
$5.91 M(-20.1%)
Dec 2015
$7.39 M(-42.8%)
$7.39 M(-20.1%)
Sept 2015
-
$9.26 M(-15.3%)
June 2015
-
$10.93 M(-7.9%)
Mar 2015
-
$11.86 M(-8.2%)
Dec 2014
$12.92 M(+116.3%)
$12.92 M(+193.8%)
Sept 2014
-
$4.40 M(-11.9%)
June 2014
-
$4.99 M(-8.3%)
Mar 2014
-
$5.45 M(-8.9%)
Dec 2013
$5.97 M(+192.6%)
$5.97 M(+273.4%)
Sept 2013
-
$1.60 M(-6.2%)
June 2013
-
$1.71 M(-14.1%)
Mar 2013
-
$1.98 M(-2.8%)
Dec 2012
$2.04 M(-57.8%)
$2.04 M(-235.0%)
Sept 2012
-
-$1.51 M(+134.6%)
June 2012
-
-$645.00 K(-175.9%)
Mar 2012
-
$850.00 K(-82.4%)
Dec 2011
$4.84 M(-785.4%)
$4.84 M(+5592.9%)
Sept 2011
-
$85.00 K(-96.7%)
June 2011
-
$2.54 M(-145.9%)
Mar 2011
-
-$5.54 M(+684.6%)
Dec 2010
-$706.00 K
-$706.00 K(-118.1%)
DateAnnualQuarterly
Sept 2010
-
$3.90 M(-1126.3%)
June 2010
-
-$380.00 K(-123.0%)
Mar 2010
-
$1.66 M(-20.0%)
Dec 2009
$2.07 M(-92.1%)
$2.07 M(-76.3%)
Sept 2008
-
$8.73 M(-38.7%)
June 2008
-
$14.25 M(-31.9%)
Mar 2008
-
$20.92 M(-20.2%)
Dec 2007
$26.20 M(+142.0%)
$26.20 M(+137.0%)
Sept 2007
-
$11.05 M(-25.9%)
June 2007
-
$14.91 M(+89.6%)
Mar 2007
-
$7.86 M(-27.4%)
Dec 2006
$10.82 M(-29.9%)
$10.82 M(-21.1%)
Sept 2006
-
$13.72 M(-22.7%)
June 2006
-
$17.76 M(-15.1%)
Mar 2006
-
$20.91 M(+35.3%)
Dec 2005
$15.45 M(-54.2%)
$15.45 M(-0.5%)
Sept 2005
-
$15.53 M(-29.2%)
June 2005
-
$21.94 M(-20.2%)
Mar 2005
-
$27.50 M(-18.5%)
Dec 2004
$33.76 M(-24.3%)
$33.76 M(-17.8%)
Sept 2004
-
$41.05 M(-12.9%)
June 2004
-
$47.10 M(-11.1%)
Mar 2004
-
$52.96 M(+18.8%)
Dec 2003
$44.58 M(-36.9%)
$44.58 M(-13.2%)
Sept 2003
-
$51.39 M(-10.6%)
June 2003
-
$57.51 M(-10.4%)
Mar 2003
-
$64.16 M(-9.3%)
Dec 2002
$70.70 M(-29.4%)
$70.70 M(-10.9%)
Sept 2002
-
$79.33 M(-8.9%)
June 2002
-
$87.06 M(-7.5%)
Mar 2002
-
$94.12 M(-6.1%)
Dec 2001
$100.19 M(-13.2%)
$100.19 M(-6.7%)
Sept 2001
-
$107.37 M(-3.2%)
June 2001
-
$110.97 M(-1.5%)
Mar 2001
-
$112.66 M(-2.4%)
Dec 2000
$115.39 M(+155.8%)
$115.39 M(+49.6%)
Sept 2000
-
$77.11 M(-5.3%)
June 2000
-
$81.40 M(-2.1%)
Mar 2000
-
$83.13 M(+84.3%)
Dec 1999
$45.10 M(+342.2%)
$45.10 M(+456.8%)
Sept 1999
-
$8.10 M(-22.1%)
June 1999
-
$10.40 M(-22.4%)
Mar 1999
-
$13.40 M(+31.4%)
Dec 1998
$10.20 M(-56.8%)
$10.20 M(-24.4%)
Sept 1998
-
$13.50 M(-17.2%)
June 1998
-
$16.30 M(-11.4%)
Mar 1998
-
$18.40 M(-22.0%)
Dec 1997
$23.60 M(+93.4%)
$23.60 M(+353.8%)
Sept 1997
-
$5.20 M(-40.9%)
June 1997
-
$8.80 M(+144.4%)
Mar 1997
-
$3.60 M(-70.5%)
Dec 1996
$12.20 M(-290.6%)
$12.20 M(-22.3%)
Sept 1996
-
$15.70 M(+248.9%)
June 1996
-
$4.50 M(-34.8%)
Mar 1996
-
$6.90 M(-207.8%)
Dec 1995
-$6.40 M
-$6.40 M

FAQ

  • What is Titan Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly working capital year-on-year change?

What is Titan Pharmaceuticals annual working capital?

The current annual working capital of TTNP is $6.57 M

What is the all time high annual working capital for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual working capital is $115.39 M

What is Titan Pharmaceuticals quarterly working capital?

The current quarterly working capital of TTNP is $3.99 M

What is the all time high quarterly working capital for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly working capital is $115.39 M

What is Titan Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, TTNP quarterly working capital has changed by -$2.58 M (-39.25%)